Christopher Thomas Giordano insider trades

Open-market stock purchases and sales by Christopher Thomas Giordano, CEO at Tenax Therapeutics, Inc, from SEC Form 4 filings since Jun 9, 2022.

Track record: 0% of 4 scored buys are up 5% or more since purchase, averaging -48%.

Recent trades

DateStockTradeValue
Sep 15, 2026TENX Tenax Therapeutics, IncBought$8.8K
Sep 11, 2026TENX Tenax Therapeutics, IncBought$11.3K
Jul 13, 2026TENX Tenax Therapeutics, IncBought (not open market)$777
Jul 13, 2026TENX Tenax Therapeutics, IncBought (not open market)$50.5K
Jul 13, 2026TENX Tenax Therapeutics, IncBought (not open market)—
Jul 13, 2026TENX Tenax Therapeutics, IncBought (not open market)—
Jan 9, 2026TENX Tenax Therapeutics, IncBought (not open market)—
Nov 20, 2025TENX Tenax Therapeutics, IncBought$4.1K
Nov 19, 2025TENX Tenax Therapeutics, IncBought$3.4K
Nov 18, 2025TENX Tenax Therapeutics, IncBought$12.5K

Companies traded

  • TENX Tenax Therapeutics, Inc: 5 buys, last Sep 15, 2026

Get free alerts when Christopher Thomas Giordano files a new trade →